Common Contracts
2 similar License Agreement contracts by Oncothyreon Inc., Seattle Genetics Inc /Wa
LICENSE AGREEMENTLicense Agreement • April 26th, 2018 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
This License Agreement (this “Agreement”), entered into as of December 11, 2014 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having offices at 3200 Walnut Street, Boulder, Colorado 80301, and Oncothyreon Inc., a Delaware corporation, having offices at 2601 Fourth Ave., Suite 500, Seattle WA 98121.
LICENSE AGREEMENTLicense Agreement • March 10th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research • New York
All ancillary compounds and materials associated with the development and characterization of ARRY-380 drug product and drug substance; including but not limited to:
